Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.

This research paper studies changes in reticulocytes, immature red blood cells, in horses under conditions of induced anemia and treatment with erythropoietin (EPO). The study finds that these conditions result in significant changes in reticulocyte characteristics, contrary to prior beliefs.

Objective and Methodology

• This paper examines how reticulocytes, immature red blood cells capable of carrying oxygen, change in horses when they’re subjected to anemia and then treated with EPO, a hormone that stimulates the production of red blood cells.
• Anemia was induced in six horses via the removal of a large volume of blood, after which they were treated with EPO. The ability to scrutinize reticulocytes was enabled through the use of a modern hematology analyzer known as the ADVIA120 instrument.
• Blood and bone marrow samples were taken and analyzed at various intervals across the study.

Findings and Significance

• The results showed that anemia and EPO treatment led to significant increases in red cell distribution width and reticulocyte mean cell volume.
• Additional parameters that only changed following EPO treatment included cellular hemoglobin concentration mean, mean cell volume, reticulocyte concentration, the proportion of larger-than-normal reticulocytes, and reticulocyte cellular hemoglobin.
• The ANOVA statistical method was used to determine significant changes in reticulocyte parameters, following a randomized complete block design.
• A noteworthy finding from this research is that contrary to previous understanding, horses do release reticulocytes from the bone marrow into their circulation under severe erythropoietic stress, such as after having anemia induced or being treated with EPO.
• This study therefore provides new insights into equine biology and medicine, specifically with regard to blood cell production and medical interventions for conditions like anemia.